SI
EGRX

Scout Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Scout Investments’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-131,192
Closed -$2M – 221
2023
Q3 		$2M Sell
131,192
-3,815
-3% -$68.5K 0.05% 211
2023
Q2 		$2.53M Sell
135,007
-4,051
-3% -$96.1K 0.05% 210
2023
Q1 		$3.95M Sell
139,058
-1,584
-1% -$47K 0.08% 197
2022
Q4 		$4.11M Sell
140,642
-2,342
-2% -$74.5K 0.08% 196
2022
Q3 		$3.78M Sell
142,984
-4,050
-3% -$149K 0.08% 207
2022
Q2 		$6.53M Sell
147,034
-22,204
-13% -$1.02M 0.13% 175
2022
Q1 		$8.38M Sell
169,238
-228
-0.1% -$10.9K 0.13% 168
2021
Q4 		$8.63M Sell
169,466
-3,820
-2% -$198K 0.13% 204
2021
Q3 		$9.67M Sell
173,286
-3,627
-2% -$178K 0.14% 198
2021
Q2 		$7.57M Buy
176,913
+30,664
+21% +$1.27M 0.11% 229
2021
Q1 		$6.1M Buy
146,249
+14,280
+11% +$663K 0.09% 249
2020
Q4 		$6.15M Buy
131,969
+3,500
+3% +$164K 0.11% 247
2020
Q3 		$5.46M Buy
128,469
+44,114
+52% +$1.93M 0.12% 232
2020
Q2 		$4.05M Sell
84,355
-386
-0.5% -$19.3K 0.1% 236
2020
Q1 		$3.9M Sell
84,741
-5,109
-6% -$256K 0.12% 209
2019
Q4 		$5.4M Sell
89,850
-1,500
-2% -$89.5K 0.1% 211
2019
Q3 		$5.17M Sell
91,350
-7,460
-8% -$420K 0.1% 207
2019
Q2 		$5.5M Buy
98,810
+43,815
+80% +$2.29M 0.11% 201
2019
Q1 		$2.78M Sell
54,995
-1,316
-2% -$58.6K 0.06% 247
2018
Q4 		$2.27M Buy
56,311
+11,289
+25% +$582K 0.06% 240
2018
Q3 		$3.12M Buy
+45,022
New +$3.41M 0.06% 246

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Scout Investments's EGRX Position: Q4 2023 in Review

Scout Investments sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2023, closing a stake of 131,192 shares — an estimated $2M sold.

Scout Investments first reported a position in EGRX in Q3 2018 and held it in 21 quarters. The position peaked at $9.67M in Q3 2021. 104 funds tracked by Wall St. Rank hold EGRX as of Q4 2023.

  • Scout Investments reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Scout Investments sold 131,192 Eagle Pharmaceuticals, Inc. shares in Q4 2023, an estimated $2M.
  • Scout Investments first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2018 and held it in 21 quarters.
  • Scout Investments's Eagle Pharmaceuticals, Inc. position peaked at $9.67M in Q3 2021.
  • 104 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2023.

Based on Scout Investments's 13F filing for Q4 2023, filed 13 Feb 2024.